跳至主要内容
临床试验/IRCT20230312057694N1
IRCT20230312057694N1招募中3 期

The effect of furosemide in the prevention of contrast-induced nephropathy in STEMI (ST) Elevation Myocardial Infarction patients undergoing Percutaneous Coronary Intervention (PCI) referred to Golestan Hospital between 2023-2024

Ahvaz University of Medical Sciences0 个研究点目标入组 234 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
234

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Those who are willing to participate in the study
  • Patients whose clinical information is complete
  • Patients whose disease has been confirmed as STEMI and are candidates for angiography and angioplasty

排除标准

  • Patients who do not agree to participate in the study
  • Patients whose clinical information is not complete
  • Patients with heart failure
  • Dialysis patients who do not pass urine

研究者

相似试验